Talking With Docs brings you news and instructional videos regarding health in an entertaining way. Through short, ...

Out and about in Waterford . Pictured at a coffee morning at the Viking Hotel Waterford in aid of COPD, seated, Danny Myler, ...

Pope Francis, who passed away earlier this week at age 88, made history when he was elected pope. Not only was he the first Jesuit pope, he was the first pope from South America—the first pope ...

COPD is a disease that damages your lungs over time. It may start with mild symptoms and then get worse. Treatment can help symptoms and slow disease progression. Chronic obstructive pulmonary ...

Photos show powerful moments from the late pope's funeral proceedings. After Pope Francis' death was announced on Easter Monday, mourners assembled for an evening rosary prayer in St. Peter's Square.

As chronic obstructive pulmonary disease (COPD) gets worse, it limits your airflow more and more. By stage II, your symptoms are usually no longer something you can just shrug off. They start to ...

As chronic obstructive pulmonary disease (COPD) reaches stage III, it starts to have a bigger impact on the way you live your life. The condition may sap your strength and make it hard to work or ...

Slate says its new 201-hp electric vehicle is "a radical truck platform so customizable that it can transform from a 2-seat pickup to a 5-seat SUV.” They claim it'll go 150 miles on a 52.7-kWh ...

It is not known exactly when the photos were hung, but they are further evidence of how deeply embedded Rauchet has become in the Pentagon. Her constant presence has reportedly rattled staffers ...

It’s official: the massive new pool (and year-round community hub) at the northern tip of Central Park is finally opening, and the first photos are here to prove it’s even more stunning than ...

Photos posted by Meyer show Stewart in a little gray patterned, cropped button-up and skirt set, styled with a plain white T-shirt. Meyer went bridal in a semi-sheer white blouse and silky ivory ...

COPD represents a significant opportunity for Sanofi and its U.S. drug partner Regeneron as Dupixent is the first biologic approved for the condition, which is the fourth-leading cause of death in ...